BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31832570)

  • 1. Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis.
    Maras JS; Das S; Bhat A; Kumar Vyas A; Yadav G; Chaudhary S; Sukriti S; Gupta AC; Bihari C; Mahiwall R; Sarin SK
    Hepatol Commun; 2019 Dec; 3(12):1598-1625. PubMed ID: 31832570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis.
    Bhat A; Das S; Yadav G; Chaudhary S; Vyas A; Islam M; Gupta AC; Bajpai M; Maiwall R; Maras JS; Sarin SK
    Hepatol Commun; 2020 Jan; 4(1):50-65. PubMed ID: 31909355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.
    Rosenblat M; Vaya J; Shih D; Aviram M
    Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis.
    Das S; Maras JS; Maiwall R; Shasthry SM; Hussain S; Sharma S; Sukriti S; Singh TP; Sarin SK
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1322-1332.e4. PubMed ID: 29155355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages.
    Berrougui H; Loued S; Khalil A
    Free Radic Biol Med; 2012 Apr; 52(8):1372-81. PubMed ID: 22336243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis.
    Das S; Maras JS; Hussain MS; Sharma S; David P; Sukriti S; Shasthry SM; Maiwall R; Trehanpati N; Singh TP; Sarin SK
    Hepatology; 2017 Feb; 65(2):631-646. PubMed ID: 27775820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.
    Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M
    Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification Patterns of Urinary Albumin Correlates With Serum Albumin and Outcome in Severe Alcoholic Hepatitis.
    Das S; Hussain MS; Maras JS; Kumar J; Shasthry SM; Nayak S; Arora V; Vijayaraghavan R; Sharma S; Maiwall R; Sarin SK
    J Clin Gastroenterol; 2019 Jul; 53(6):e243-e252. PubMed ID: 29369844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
    Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
    Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
    Sutherland WH; de Jong SA; Walker RJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
    Berrougui H; Khalil A
    Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.